Document is current

Article History

Received: 7 March 2024

Accepted: 10 May 2024

First Online: 20 August 2024

Declarations

:

: S.M.: UpToDate Royalties; M.G., for the CAPABLe trial, equipment was purchased at or below cost from Medspira by RTI on behalf of the PFDN in return for PFDN consultation on mcompass biofeedback software modifications.

: All authors have completed training in ethical research and abide by the journal’s ethics and integrity policy. All participants signed informed consent documentation. The study is registered on (NCT 03278613).

: IRB approvals through the following institutions at the time of the study/data collection: University of Alabama at Birmingham, Birmingham, AL, USA; University of Pittsburgh/Magee-Women’s Research Institute, Pittsburgh, PA, USA; University of Pennsylvania, Philadelphia, PA, USA; Cleveland Clinic, Cleveland, OH, USA; Kaiser Permanente San Diego, San Diego, CA, USA; Warren Alpert Medical School of Brown University, Women’s & Infants Hospital, Providence, RI, USA; University of New Mexico Medical School, Albuquerque, NM, USA; University of California, San Diego Health, San Diego, CA, USA.